An Inquiry Into Needs- Based Allocation of Health Care Resources

“Pee test lets mums-to-be see into future”

P.POONGODI - Professor-OBG Department
Faculty of Nursing
Dr.M.G.R. Educational and Research Institute (Deemed to be University)

INTRODUCTION METHODS RESULTS

• Home test can confirm the pregnancy.
• MAP(Maternal Alpha-Feto Protein) analyzes the patterns
of protein in mothers urine for information about the
health of an expectant mother and her baby.
• It is a new non-invasive pre-natal diagnostic method
mother can do in home itself and Identify a healthy
pregnancy or high risk pregnancy by herself.
• Using algorithms to predict the outcome of a pregnancy
based on the proteins in a woman’s urine
•Home test • Home test can confirm within 5 minutes to identify the
•Pharmacy Kit normal or high risk pregnancy.
•Eight weeks of pregnant mother
• More accurate
•Urine sample
•Lab Test • Economical
• Non invasive prenatal diagnosis
•Matrix-Assisted laser desorption ionization (MALDI)
•Spin out the separate proteins from the urine and then • Lab test can confirm within 15 minutes by Time –of-Fight
analyze these proteins for patterns . Mass Spectrometer.

“Stephen Butler MAP Founder

and Chief Scientific Officer”

CONCLUSION
•Promising global practices to improve maternal health outcomes was well
received by participants and provided a unique opportunity to identify best
practices.
• To reduce maternal mortality and morbidity from international and
domestics subject matter experts and leaders in the field of maternal health.
• As per sustainable development goal 3 this MAP diagnostic test will help
you to identify the early complications of high risk pregnancies.
RECOMMENDATIONS
Nursing Practice
1.Conduct awareness program to make the mothers and general public aware of the
newer diagnostic MAP test as an effective way to prevent complications and risk
associated during antenatal period
2.This non-invasive prenatal diagnostic test will help to achieving the sustainable goals
target of MMR below 70 by 2030
REFERENCES
1. O'Leary P, Breheny N, Dickinson JE, et al. First-trimester combined screening for Down
syndrome and other fetal anomalies. Obstetric Gynecology 2015; 107: 869-876.

2. Hadlow NC, Hewitt BG, Dickinson JE, et al. Community-based screening for Down's syndrome
in the first trimester using ultrasound and maternal biochemistry. BJOG 2005; 112: 1561-1564.

3. www.healthline.com